33.76
price up icon6.26%   1.99
after-market Dopo l'orario di chiusura: 33.40 -0.36 -1.07%
loading
Precedente Chiudi:
$31.77
Aprire:
$32.06
Volume 24 ore:
1.66M
Relative Volume:
0.98
Capitalizzazione di mercato:
$4.17B
Reddito:
$692.26M
Utile/perdita netta:
$-512.41M
Rapporto P/E:
-7.9623
EPS:
-4.24
Flusso di cassa netto:
$-274.36M
1 W Prestazione:
+10.91%
1M Prestazione:
-5.65%
6M Prestazione:
+18.83%
1 anno Prestazione:
+33.02%
Intervallo 1D:
Value
$31.72
$33.82
Intervallo di 1 settimana:
Value
$29.91
$33.82
Portata 52W:
Value
$15.81
$38.53

Guardant Health Inc Stock (GH) Company Profile

Name
Nome
Guardant Health Inc
Name
Telefono
855-698-8887
Name
Indirizzo
3100 HANOVER STREET, PALO ALTO
Name
Dipendente
1,779
Name
Cinguettio
@guardanthealth
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
GH's Discussions on Twitter

Confronta GH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
GH
Guardant Health Inc
33.76 4.17B 692.26M -512.41M -274.36M -4.24
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
532.02 203.50B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
234.84 169.62B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
135.69 38.75B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
197.39 35.83B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
415.53 34.03B 3.84B 866.24M 792.60M 10.37

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-28 Aggiornamento Guggenheim Neutral → Buy
2024-06-03 Ripresa Jefferies Buy
2024-04-24 Ripresa Craig Hallum Buy
2023-12-14 Iniziato Guggenheim Neutral
2023-12-13 Iniziato Wolfe Research Peer Perform
2023-11-13 Aggiornamento Raymond James Mkt Perform → Outperform
2023-09-28 Iniziato Bernstein Outperform
2023-09-27 Aggiornamento Piper Sandler Neutral → Overweight
2023-07-05 Ripresa JP Morgan Overweight
2023-05-26 Aggiornamento Citigroup Neutral → Buy
2023-05-05 Iniziato UBS Buy
2023-03-09 Downgrade Citigroup Buy → Neutral
2023-01-05 Iniziato Scotiabank Sector Outperform
2022-11-01 Downgrade Piper Sandler Overweight → Neutral
2022-10-19 Iniziato Craig Hallum Buy
2022-10-06 Iniziato Stephens Overweight
2022-08-25 Iniziato Credit Suisse Outperform
2022-06-03 Iniziato Piper Sandler Overweight
2022-04-28 Ripresa BTIG Research Buy
2022-02-24 Reiterato Canaccord Genuity Buy
2022-02-24 Reiterato Citigroup Buy
2022-02-24 Reiterato Cowen Outperform
2022-02-24 Reiterato Morgan Stanley Overweight
2022-02-24 Reiterato SVB Leerink Outperform
2022-02-24 Reiterato Stifel Buy
2022-02-24 Reiterato Wells Fargo Overweight
2021-10-15 Ripresa Cowen Outperform
2021-06-15 Iniziato Raymond James Mkt Perform
2021-06-03 Iniziato Goldman Buy
2021-05-25 Iniziato Wells Fargo Overweight
2021-01-11 Iniziato Stifel Buy
2020-09-09 Iniziato Morgan Stanley Overweight
2020-06-12 Iniziato BTIG Research Buy
2020-02-21 Iniziato Guggenheim Buy
2020-01-07 Iniziato Citigroup Buy
2019-08-07 Reiterato Canaccord Genuity Buy
2019-04-16 Iniziato Canaccord Genuity Buy
2019-04-10 Aggiornamento BofA/Merrill Neutral → Buy
2019-02-28 Reiterato BofA/Merrill Neutral
2018-10-29 Iniziato BofA/Merrill Neutral
2018-10-29 Iniziato JP Morgan Overweight
2018-10-29 Iniziato William Blair Outperform
Mostra tutto

Guardant Health Inc Borsa (GH) Ultime notizie

pulisher
Jan 03, 2025

Piper Sandler maintains Overweight on Guardant Health stock By Investing.com - Investing.com UK

Jan 03, 2025
pulisher
Jan 02, 2025

GHGuardant Health, Inc. Latest Stock News & Market Updates - StockTitan

Jan 02, 2025
pulisher
Jan 02, 2025

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Jan 02, 2025
pulisher
Jan 01, 2025

Guardant Health, Inc. (NASDAQ:GH) Sees Large Decline in Short Interest - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Why Guardant Health, Inc. (NASDAQ:GH) Could Be Worth Watching - Simply Wall St

Dec 31, 2024
pulisher
Dec 31, 2024

Natera: Poised For A Great Future But I'd Wait For A Pullback (NASDAQ:NTRA) - Seeking Alpha

Dec 31, 2024
pulisher
Dec 23, 2024

Sheffield United takeover completed by COH Sports - Reuters

Dec 23, 2024
pulisher
Dec 22, 2024

FDA approves blood-based test screens for colon cancer - MSN

Dec 22, 2024
pulisher
Dec 22, 2024

Geode Capital Management LLC Purchases 29,686 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 22, 2024
pulisher
Dec 20, 2024

Guardant Health director Tariq Musa sells $4,042 in common stock - Investing.com India

Dec 20, 2024
pulisher
Dec 20, 2024

Guardant Health Partners with MiBA to Transform Cancer Care with AI-Powered Precision Oncology - StockTitan

Dec 20, 2024
pulisher
Dec 20, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Franklin Resources Inc. - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Guardant Health director Tariq Musa sells $4,042 in common stock By Investing.com - Investing.com South Africa

Dec 20, 2024
pulisher
Dec 19, 2024

Meaningful Insights Biotech Analytics and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care - Marketscreener.com

Dec 19, 2024
pulisher
Dec 19, 2024

Guardant Health and COTA partner in advanced oncology R&D - TipRanks

Dec 19, 2024
pulisher
Dec 19, 2024

Guardant Health Partners with COTA to Revolutionize Cancer Drug Development Through AI-Powered Data - StockTitan

Dec 19, 2024
pulisher
Dec 19, 2024

Y Intercept Hong Kong Ltd Sells 38,937 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

Guardant Health teams up with Boehringer for cancer test By Investing.com - Investing.com Australia

Dec 18, 2024
pulisher
Dec 18, 2024

Guardant Health teams up with Boehringer for cancer test - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer - Business Wire

Dec 18, 2024
pulisher
Dec 18, 2024

Guardant Health Partners with Boehringer Ingelheim on Breakthrough Lung Cancer Diagnostic Test - StockTitan

Dec 18, 2024
pulisher
Dec 16, 2024

Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells 2,320 Shares of Stock - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Guardant Health director Tariq Musa sells $81,200 in stock - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

681,074 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Lord Abbett & CO. LLC - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

XTX Topco Ltd Has $409,000 Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Guardant Health, Inc. (NASDAQ:GH) Receives $40.60 Consensus Target Price from Analysts - MarketBeat

Dec 16, 2024
pulisher
Dec 14, 2024

(GH) Trading Report - Stock Traders Daily

Dec 14, 2024
pulisher
Dec 10, 2024

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal - The Eastern Progress Online

Dec 10, 2024
pulisher
Dec 10, 2024

Verition Fund Management LLC Buys 25,900 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium - The Bakersfield Californian

Dec 09, 2024
pulisher
Dec 09, 2024

Wellington Management Group LLP Purchases 6,618,785 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Guardant Health to Showcase Breakthrough Liquid Biopsy Research at Major Breast Cancer Symposium - StockTitan

Dec 09, 2024
pulisher
Dec 08, 2024

Pier Capital LLC Buys 42,575 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Bought by Two Sigma Advisers LP - MarketBeat

Dec 08, 2024
pulisher
Dec 07, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Polar Asset Management Partners Inc. - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

Temasek Holdings Private Ltd Reduces Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Charles Schwab Investment Management Inc. Has $23.01 Million Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Investors in Guardant Health (NASDAQ:GH) from three years ago are still down 61%, even after 8.6% gain this past week - Yahoo Finance

Dec 05, 2024
pulisher
Dec 05, 2024

Strong week for Guardant Health (NASDAQ:GH) shareholders doesn't alleviate pain of three-year loss - Simply Wall St

Dec 05, 2024
pulisher
Dec 05, 2024

Guardant Health stock soars to 52-week high of $37.04 By Investing.com - Investing.com Nigeria

Dec 05, 2024
pulisher
Dec 04, 2024

Guardant Health Inc (GH) Shares Up 4.11% on Dec 4 - GuruFocus.com

Dec 04, 2024
pulisher
Dec 04, 2024

Guardant Health stock soars to 52-week high of $37.04 - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

Guardant Health Stock Flashing Surefire ‘Buy’ Signal - Forbes

Dec 04, 2024
pulisher
Dec 03, 2024

The Manufacturers Life Insurance Company Sells 28,746 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Guardant Health (FRA:5GH) Shares Outstanding (EOP) : 123.2 Mil (As of Sep. 2024) - GuruFocus.com

Dec 03, 2024
pulisher
Dec 03, 2024

Liquid Biopsy Market Is Booming So Rapidly with Major Giants - openPR

Dec 03, 2024
pulisher
Dec 02, 2024

Guardant awarded nearly $293M in false ad trial against Natera - MedTech Dive

Dec 02, 2024
pulisher
Dec 01, 2024

Erste Asset Management GmbH Buys New Stake in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

Fred Alger Management LLC Sells 43,039 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

GH (Guardant Health) EBITDA per Share : $-3.86 (TTM As of Sep. 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Dec 01, 2024

Guardant Health (STU:5GH) EPS (Diluted) : €-3.89 (TTM As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Guardant Health Inc Azioni (GH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Guardant Health Inc Azioni (GH) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Kalia Kumud
Chief Information Officer
Jan 01 '25
Option Exercise
0.00
2,690
0
21,098
Freeman Chris
Chief Commercial Officer
Jan 01 '25
Option Exercise
0.00
3,595
0
35,852
EAGLE CRAIG
Chief Medical Officer
Jan 01 '25
Option Exercise
0.00
3,381
0
27,343
Chudova Darya
Chief Technology Officer
Jan 01 '25
Option Exercise
0.00
3,006
0
57,786
Bell Michael Brian
Chief Financial Officer
Jan 01 '25
Option Exercise
0.00
2,084
0
27,772
Talasaz AmirAli
Co-Chief Executive Officer
Dec 31 '24
Option Exercise
0.00
11,462
0
2,215,894
Talasaz AmirAli
Co-Chief Executive Officer
Jan 01 '25
Option Exercise
0.00
94,555
0
2,304,640
Eltoukhy Helmy
Co-Chief Executive Officer
Dec 31 '24
Option Exercise
0.00
11,462
0
2,315,728
Eltoukhy Helmy
Co-Chief Executive Officer
Jan 01 '25
Option Exercise
0.00
94,555
0
2,404,474
Krognes Steve E.
Director
Dec 31 '24
Option Exercise
0.00
155
0
10,220
diagnostics_research LH
$229.15
price up icon 0.42%
$136.01
price up icon 3.88%
diagnostics_research WAT
$371.76
price up icon 0.95%
$167.60
price up icon 4.36%
diagnostics_research MTD
$1,238.28
price up icon 1.43%
$415.53
price up icon 1.63%
Capitalizzazione:     |  Volume (24 ore):